AzTrials
AzTrials

Osteoarthritis, KneeCOPANCT06514443

Barriers and Faciliators for Physical Activity in People With RMDs

An observational study of Osteoarthritis, Knee and Osteoarthritis, Hip, run by Anne-Kathrin Rausch.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this project is to systematically survey and explore barriers and facilitators for the implementation of physical activity according to the physical activity recommendations of the European Alliance of Associations for Rheumatology on country specific (e.g., environmental, cultural, organization and system)… Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
survey
How many people
400 participants
Where
No sites listed yet
Study dates
1 Aug 2024to 31 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Adult, Older adult

Study population: people with osteoarthritis, rheumatoid arthritis or axial Spondyloarthritis living in Turkey, the Netherlands, France or Switzerland

Who may be able to join

  • adults being 18years or older
  • diagnosis of osteoarthritis, rheumatoid arthritis or axial Spondyloarthritis
  • the cognitive and linguistic competencies to answer the survey

Who cannot join

  • having a rheumatological or musculoskeletal disease other than described
  • any communication problems

About this study

Official title: Exploration of Country-specific Barriers and Facilitators for the Implementation of Physical Activity According to the EULAR Physical Activity Recommendations for People With Rheumatic Musculoskeletal Diseases in Four Different European Countries; the COPA Project

The aim of this project is to systematically survey and explore barriers and facilitators for the implementation of physical activity according to the physical activity recommendations of the European Alliance of Associations for Rheumatology on country specific (e.g., environmental, cultural, organization and system) level. A questionnaire to explore/identify these barriers and facilitators in the survey, will be developed through literature search, interviews with multiple stakeholders (i.e., patients with inflammatory arthritis or osteoarthritis and physical therapists) and experts in the field in four different European countries (i.e., Turkey, Switzerland, the Netherlands and France).

Additionally, in Switzerland only, the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors on personal level, will be translated into the German language. Aim is to evaluate the validity and reliability of the IFAB Questionnaire in the German-speaking population with axial Spondyloarthrits, and to perform a cultural adaptation if necessary at the same time.

Being tested
survey
Medical subject headings
Osteoarthritis, Knee, Osteoarthritis, Hip, Arthritis, Rheumatoid, Axial Spondyloarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surveyOther

    survey exploring barriers and faciltiators for physical activity

Study groups in NCT06514443
Study groupRoleWhat they receive
osteoarthritsadults with hip or knee osteoarthritis
Receives: Other: survey
inflammatory arthritisadults with rheumatoid arthritis or axial Spondyloarthritis
Receives: Other: survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. barriers and facilitators for physical activity

    factors on social, envirionmental or system level impacting the physial activity behaviour

    Measured: September-December 2024

Secondary outcomes (2)
  1. reliability of the IFAB

    ONLY Swiss participants with axSpA

    Measured: September-December 2024

  2. validity of the IFAB

    ONLY Swiss participants with axSpA

    Measured: September-December 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2024
  2. Study start1 Aug 2024 (estimated)
  3. Primary completion23 Dec 2024 (estimated)
  4. Study completion31 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06514443
Sponsor's protocol ID
Zurich UAS
Acronym
COPA
Status last verified
Jul 2024
First submitted
16 Jul 2024
Last updated
23 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoarthritis, Knee and Osteoarthritis, Hip, run by Anne-Kathrin Rausch.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

barriers and facilitators for physical activity (time frame: September-December 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in